LMLynda M. McDowell

Lynda M. McDowell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lynda M. McDowell has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Barbara Poliks

    Binghamton University

    2 shared publications
  • Daniel R. Studelska

    Washington University, One

    2 shared publications
  • Jacob Schaefer

    Washington University, One

    2 shared publications
  • Robert D. O'Connor

    Washington University, One

    2 shared publications
  • Damian Arnaiz

    Department of Chemistry, Washington University, One Brookings Drive, St. Louis, Missouri 63130, Berlex Biosciences, 15049 San Pablo Avenue, Richmond, California 94804, Department of Physics, State University of New York at Binghamton, Binghamton, New York 13902

    1 shared publication
  • David R. Light

    Department of Chemistry, Washington University, One Brookings Drive, St. Louis, Missouri 63130, Berlex Biosciences, 15049 San Pablo Avenue, Richmond, California 94804, Department of Physics, State University of New York at Binghamton, Binghamton, New York 13902

    1 shared publication

Latest Publications

  • Rotational-echo double-resonance NMR-restrained model of the ternary complex of 5-enolpyruvylshikimate-3-phosphate synthase

    by Lynda M. McDowell, Barbara Poliks, Daniel R. Studelska, Robert D. O'Connor, Denise D. Beusen, Jacob Schaefer

    The 46-kD enzyme 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase catalyzes the condensation of shikimate-3-phosphate (S3P) and phosphoenolpyruvate to form EPSP. The reaction is inhibited by N-(phosphonomethyl)-glycine (Glp), which, in the presence of S3P, binds to EPSP synthase to form a stable ternary complex. We have used solid-state NMR and molecular modeling to characterize the EPSP synthase–S3P–Glp ternary complex. Modeling began with the crystal coordinates of the unliganded protein, published distance restraints, and information from the chemical modification and mutagenesis literature on EPSP synthase. New inter-ligand and ligand-protein distances were obtained. These measurements utilized the native 31P in S3P and Glp, biosynthetically 13C-labeled S3P, specifically 13C and 15N labeled Glp, and a variety of protein-15N labels. Several models were investigated and tested for accuracy using the results of both new and previously published rotational-echo double resonance (REDOR) NMR experiments. The REDOR model is compared with the recently published X-ray crystal structure of the ternary complex, PDB code 1G6S. There is general agreement between the REDOR model and the crystal structure with respect to the global folding of the two domains of EPSP synthase and the relative positioning of S3P and Glp in the binding pocket. However, some of the REDOR data are in disagreement with predictions based on the coordinates of 1G6S, particularly those of the five arginines lining the binding site. We attribute these discrepancies to substantive differences in sample preparation for REDOR and X-ray crystallography. We applied the REDOR restraints to the 1G6S coordinates and created a REDOR-refined xray structure that agrees with the NMR results.


  • Human Factor Xa Bound Amidine Inhibitor Conformation by Double Rotational-Echo Double Resonance Nuclear Magnetic Resonance and Molecular Dynamics Simulations

    by Lynda M. McDowell, Margaret A. McCarrick, Daniel R. Studelska, Robert D. O'Connor, David R. Light, William J. Guilford, Damian Arnaiz, Marc Adler, Jerry L. Dallas, Barbara Poliks, et al.

    Double rotational-echo double resonance (double REDOR) NMR was used to investigate the conformation of a 13C-, 15N-, and 19F-labeled inhibitor (Berlex Biosciences compound no. ZK-806299) bound to human factor Xa. Conformationally dependent carbon−fluorine dipolar couplings were measured by 13C{19F} REDOR. Natural abundance carbon signals in the full-echo spectra were removed by 13C{15N} REDOR. Major and minor binding modes were suggested by the NMR data, but only the former had adequate signal to noise for distance determinations. Molecular dynamics simulations restrained by double-REDOR-determined intramolecular 13C−19F distances revealed two models for the dominant binding mode that are consistent with the NMR data. We conclude that ZK-806299 binds similarly to both FXa. Moreover, it appears to bind to FXa in a fashion previously demonstrated for ZK-807834, a more selective FXa inhibitor.